Our investments

Theraclion

Theraclion (Alternext: ALTHE), a French company founded in 2004, is a spin-off of Edap-Technomed, a pioneer in the use of ultrasound for therapeutic purposes. Theraclion develops, manufactures and sells the Echopulse device that allows a non-invasive and ambulatory treatment of breast fibroadenoma and thyroid nodules.

Benefiting from the support of an international scientific and medical committee made up of surgeons, radiologists, gynaecologists, endocrinologists, nephrologists and physicians, the company relies on the expertise of engineers, doctors and businessmen to offer health professionals and patients a simple, effective and sound solution.

Dr Philippe Pouletty is a Board member.

www.theraclion.com

First FinTech Closing
On the 15th of November 2017, Truffle has successfully completed the first closing of its institutional fund Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.
Premier closing FinTech
Le 15/11/2017, Truffle réalise le premier closing de son fonds institutionnel Truffle Financial Innovation Fund.